Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Invernizzi

Showing results (231-240 of 420) with videos related to

Pageof 42
Sort By:
Hepatology Communications|August 25, 2020
Coronavirus Disease 2019 in Autoimmune Hepatitis: A Lesson From Immunosuppressed PatientsAlessio Gerussi, Cristina Rigamonti, Chiara Elia, et al.
Hepatology (Baltimore, Md.)|November 2, 2010
Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liverGerald U Denk, Silvia Maitz, Ralf Wimmer, et al.
Hepatology (Baltimore, Md.)|April 27, 2016
The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in miceNan Wu, Fanyin Meng, Pietro Invernizzi, et al.
Journal of Autoimmunity|April 12, 2014
The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injuryHaiyan Zhang, Yuan Liu, Zhaolian Bian, et al.
Hepatology (Baltimore, Md.)|February 3, 2009
Apotopes and the biliary specificity of primary biliary cirrhosisAna Lleo, Carlo Selmi, Pietro Invernizzi, et al.
Journal of Hepatology|April 21, 2009
Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populationsAtsushi Tanaka, Saeko Nezu, Satoko Uegaki, et al.
Expert Review of Gastroenterology & Hepatology|December 16, 2025
Primary biliary cholangitis (PBC): evolving approaches and expert perspectivesPietro Invernizzi, Aghemo Alessio Michele Goffredo, Vincenza Calvaruso, et al.
Hepatology (Baltimore, Md.)|June 29, 2016
Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2(-/-) miceHannah Jones, Laura Hargrove, Lindsey Kennedy, et al.
Hepatology (Baltimore, Md.)|July 9, 2009
Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severityBihui Zhong, Pavel Strnad, Carlo Selmi, et al.
Annals of Internal Medicine|October 3, 2007
Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasisDomenico Alvaro, Gianpiero Macarri, Maria Grazia Mancino, et al.
Pageof 42

Showing results (231-240 of 420) with videos related to

Sort By:
Pageof 42
Hepatology Communications|August 25, 2020
Coronavirus Disease 2019 in Autoimmune Hepatitis: A Lesson From Immunosuppressed PatientsAlessio Gerussi, Cristina Rigamonti, Chiara Elia, et al.
Hepatology (Baltimore, Md.)|November 2, 2010
Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liverGerald U Denk, Silvia Maitz, Ralf Wimmer, et al.
Hepatology (Baltimore, Md.)|April 27, 2016
The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in miceNan Wu, Fanyin Meng, Pietro Invernizzi, et al.
Journal of Autoimmunity|April 12, 2014
The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injuryHaiyan Zhang, Yuan Liu, Zhaolian Bian, et al.
Hepatology (Baltimore, Md.)|February 3, 2009
Apotopes and the biliary specificity of primary biliary cirrhosisAna Lleo, Carlo Selmi, Pietro Invernizzi, et al.
Journal of Hepatology|April 21, 2009
Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populationsAtsushi Tanaka, Saeko Nezu, Satoko Uegaki, et al.
Expert Review of Gastroenterology & Hepatology|December 16, 2025
Primary biliary cholangitis (PBC): evolving approaches and expert perspectivesPietro Invernizzi, Aghemo Alessio Michele Goffredo, Vincenza Calvaruso, et al.
Hepatology (Baltimore, Md.)|June 29, 2016
Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2(-/-) miceHannah Jones, Laura Hargrove, Lindsey Kennedy, et al.
Hepatology (Baltimore, Md.)|July 9, 2009
Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severityBihui Zhong, Pavel Strnad, Carlo Selmi, et al.
Annals of Internal Medicine|October 3, 2007
Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasisDomenico Alvaro, Gianpiero Macarri, Maria Grazia Mancino, et al.
Pageof 42